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Abstract 
Kinetics of a recombinant uridine diphosphate-glucose: sterol glycosyltransferase from Micromonospora rhodorangea 
ATCC 27932 (MrSGT) were studied using a number of sterols (including phytosterols) as glycosyl acceptors. The lowest 
Km value and the highest catalytical efficiency (kcat/Km) were found when β-sitosterol was the glycosyl acceptor in the 
enzymatic reaction. In contrast to the enzyme’s flexibility toward the glycosyl acceptor substrate, this recombinant 
enzyme was highly specific to uridine diphosphate (UDP)-glucose as the donor substrate. Besides, the UDP-glucose-
dependent MrSGT was able to attach one glucose moiety specifically onto the C-3 hydroxyl group of other phytos-
terols such as fucosterol and gramisterol, yielding stereo-specific fucosterol-3-O-β-d-glucoside and gramisterol-3-
O-β-d-glucoside, respectively. Based on kinetic data obtained from the enzyme’s reactions using five different sterol 
substrates, the significance of the alkene (or ethylidene) side chains on the C-24 position in the sterol scaffolds was 
described and the possible relationship between the substrate structure and enzyme activity was discussed. This 
is the first report on the enzymatic bioconversion of the above two phytosteryl 3-O-β-glucosides, as well as on the 
discovery of a stereospecific bacterial SGT which can attach a glucose moiety in β-conformation at the C-3 hydroxyl 
group of diverse sterols, thus highlighting the catalytic potential of this promiscuous glycosyltransferase to expand 
the structural diversity of steryl glucosides.
Keywords: UDP-glucose sterol glycosyltransferase, Kinetics, Fucosterol-3-O-β-d-glucoside, Gramisterol-3-O-β-d-
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Introduction
Uridine diphosphate (UDP)-glucose (Glc) sterol glycosyl-
transferases (SGTs) belong to family 1 of the 97 families 
of glycosyltransferases (GTs), which catalyze the trans-
fer of the sugar moiety from the nucleotide activated 
glycosyl donors onto the nucleophile acceptors (http://
www.cazy.org). SGTs are known for the glycosylation of 
specific acceptors such as sterols (including steroids and 
steroidal alkaloids), yielding their respective glycosides 
(Paquette et al. 2003; Chaturvedi et al. 2011; Stucky et al. 
2015). They are ubiquitously present in diverse eukary-
otic organisms (mainly in plants), and the presence of 
their catalytic products—phytosterol glycosides (PSGs)—
in these organisms might be responsible for physiological 
functions such as the adaptive responses against biotic 
or abiotic stresses (Madina et al. 2007; Chaturvedi et al. 
2011; Shin et al. 2012; Saema et al. 2016).
A free C-3 hydroxyl position in the phytosterols has 
been the most preferable and acceptable site for the 
SGT’s catalytic biosynthesis of PSGs (Tiwari et al. 2014), 
followed by other hydroxyl groups on the side chain 
of sterol scaffolds. Some SGTs specifically transfer the 
sugar moiety onto hydroxyl groups other than the one 
on C-3 (Madina et  al. 2007; Malik et  al. 2013). In addi-
tion, the stereo-chemical conformation of O-glycosidic 
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bond present in the PSGs was mainly in β-conformation 
(Chaturvedi et al. 2011; Tiwari et al. 2014).
There have been several studies reviewing the catalytic 
and biochemical properties of plant SGTs, and the struc-
tural features and the biological functions of PSGs bio-
synthesized by these enzymes (Chaturvedi et  al. 2011). 
However, studies on bacterial SGTs have been relatively 
fewer (Smith 1971; Wunder et  al. 2006; Lebrun et  al. 
2006; Thuan et al. 2013). SGT from Helicobacter (a causa-
tive agent of peptic or stomach ulcer) glycosylates host 
cholesterol, thus causing this glycoside to be presented 
on the outer cell membrane, which in turn confers resist-
ance against the host immune response (Wunder et  al. 
2006). In 2013, one putative SGT-encoding gene was iso-
lated from a marine actinomycete, Salinispora tropica 
CNB-440; the complete genome sequence of this organ-
ism has been published (GenBank Accession Number 
NC_009380.1). After the heterologous expression of the 
cloned gene in Escherichia coli, the in vitro catalytic func-
tion of the gene products has been verified as that of SGT 
(Thuan et al. 2013).
Recently, we isolated and sequenced an open reading 
frame expected to encode SGT, from the fosmid libraries 
of Micromonospora rhodorangea ATCC 27932 (depos-
ited as GenBank Accession Number KT983252), using 
specific degenerate PCR primers (Hoang et  al. 2016). 
The recombinant gene product, MrSGT, expressed in E. 
coli BL21(DE3) as a His-tagged protein, was shown to be 
capable of transferring a glucosyl moiety from UDP-Glc 
to the free C-3 hydroxyl position of phytosterols (includ-
ing β-sitosterol and campesterol) and cholesterol. More 
detailed kinetic studies of this MrSGT, using a number of 
sterol substrates, are essential for further investigation of 
its applicability as a potential tailoring biocatalyst.
In this study, the substrate flexibility of the recombi-
nant MrSGT and the substrate structure-enzyme activ-
ity relationship are examined through the comparative 
kinetic analyses of the purified MrSGT enzyme action 
on different sterol substrates. In addition, two new PSG 
derivatives of fucosterol and gramisterol, whose struc-




The purified His-tagged recombinant MrSGT was pre-
pared as previously described in our recent publica-
tion (Hoang et  al. 2016). The authentic sterols such as 
β-sitosterol, campesterol and cholesterol (Fig.  1) were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). 
MrSGT (2  μM) was incubated with each of the above 
three sterols (glycosyl acceptors) and UDP-Glc (Sigma-
Aldrich) as a glycosyl donor, in 100  μL reaction buffer 
(50  mM Tris–HCl, pH 7.4; 5  mM MgCl2) at 30  °C for 
15 min. For the determination of the kinetic parameters 
for each sterol, the concentration of UDP-Glc was fixed 
at 0.8 mM, while the concentration of the sterol was var-
ied from 0.05 to 0.6  mM. To measure the kinetic prop-
erties with respect to UDP-Glc, the concentration of the 
sterol was kept constant at 0.6  mM, while the concen-
tration of UDP-Glc was varied from 0.1 to 0.8  mM. All 
reactions were quenched by the addition of 100  μL of 
ethyl acetate. After the evaporation of the solvent layer to 
dryness, aliquots of extracts, reconstituted in methanol, 
were subjected to HPLC–MS/MS analyses as described 
below. Each experiment was performed in triplicate, and 
the reaction mixture containing boiled MrSGT served as 
control.
HPLC–MS/MS analyses
Qualitative analyses of the sterols and sterol glucosides 
(including β-sitosterol-3-O-β-d-glucoside, campesterol-
3-O-β-d-glucoside and cholesterol-3-O-β-d-glucoside) 
obtained from the in  vitro MrSGT reactions were con-
ducted by HPLC-tandem mass spectrometry (MS/MS; 
ThermoFinnigan, San Jose, CA, USA) as described before 
(Hoang et al. 2016). In brief, isocratic elution (methanol:
acetonitrile:water:formic acid =  45:40:14.8:0.2 [v/v/v/v]) 
was performed on an Acquity CSH C18 reversed-phase 
column (Waters, Milford, MA, USA; 2.1  ×  50  mm, 
1.7 μm) at a flow rate of 120 μL/min. The column efflu-
ent was introduced into the MS/MS (without splitting), 
which was operated in the positive ion mode. Acquisition 
was performed using MS/MS operated in the selective 
reaction monitoring (SRM) mode by choosing six differ-
ent sets of mass transitions specific to both sterols and 
the corresponding sterol glucosides to detect the transi-
tion of the protonated precursor ion to the dominant 
product ion (415.5 [M+H]+  >  397.5 [M-H2O+H]+ as a 
dehydrated product ion for β-sitosterol; 401.5  >  383.5 
for campesterol; 387.5  >  369.5 for cholesterol; 
577.5  >  399.5 [M-Glc+H]+ as an aglycone product 
ion for β-sitosterol-3-O-β-dglucoside; 563.5  >  385.5 
for campesterol-3-O-β-d-glucoside; 549.5  >  371.5 for 
cholesterol-3-O-β-d-glucoside).
Glucosylation of fucosterol and gramisterol using MrSGT
The glucosylation of two PSs, whose glucosides have 
not been exactly described, was examined using puri-
fied MrSGT. Authentic fucosterol was obtained from 
Sigma-Aldrich and authentic gramisterol from Leancare 
Ltd. (Flintshire, UK) (Fig. 1). Reactions to determine the 
glycosyltransferase activity of MrSGT on fucosterol and 
gramisterol, were performed as follows; MrSGT dis-
solved in the above-mentioned reaction buffer was incu-
bated with 0.6  mM each of fucosterol and gramisterol, 
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respectively, along with 0.8  mM of UDP-Glc at 30  °C 
for 15  min, and then extracted by organic solvent par-
tition. The formation of the corresponding glucosides 
was analyzed by HPLC–MS/MS as stated before. Each 
experiment was performed in duplicate, and the reaction 
mixture with boiled MrSGT served as control.
Isolation and structural elucidation of two new PSG 
derivatives biosynthesized
To produce sufficient quantities of the two PSG deriva-
tives for the purpose of elucidating their chemical struc-
ture, multiple scale-up reactions were carried out as 
follows; the molar concentrations of PSs, UDP-Glc and 
MrSGT enzyme were maintained in the proportions 
described above, while scaling up the total volume of 
the reaction mixture to 1  mL. At the end of the reac-
tion, reaction mixtures from more than five batches were 
pooled and extracted by ethyl acetate partitioning. The 
solvent layer obtained was evaporated to dryness using 
a centrifugal evaporator (EYELA, Tokyo, Japan) set at 
40 °C, and reconstituted in 5 mL of the mobile phase used 
for the HPLC–MS/MS analyses. The extracts were imme-
diately loaded onto a reverse-phase C8 cartridge of the 
CombiFlash Rf medium-pressure liquid chromatography 
(MPLC) system (Teledyne ISCO, Lincoln, NE, USA), and 
the flow rate was set at 8  mL/min. The eluents passing 
through a UV detector were all automatically fraction-
ated over a 50-min running time. The fractions confirmed 
to contain the PSG derivative with a good purity (>97 %) 
by the tracing HPLC–MS/MS analyses, were pooled and 
freeze-dried. Their structures were further confirmed by 
Varian INOVA 500 nuclear magnetic resonance (NMR, 
Varian Inc., Palo Alto, CA, USA) spectroscopic analysis 
together with high resolution (HR) LCT-premier XE MS 
(Waters, Milford, MA, USA) analysis.
Results
Physiological optimum of MrSGT
Prior to examining the kinetic parameters of recombi-
nant MrSGT, the optimum pH and temperature for the 
glycosyl-transferring reaction of the enzyme were inves-
tigated using β-sitosterol as the sterol acceptor, which 
has been determined in a previous publication (Hoang 
et al. 2016), to exhibit the highest conversion yield among 
three different sterols. The enzyme might be stable 
(>90 % relative activity) within the pH range of 6–8, but 
its catalytic activity was substantially lost in further alka-
line conditions (data not shown). When the temperature 
was varied between 20 and 50 °C, the maximum activity 
was found at 30 °C.
Kinetic analyses of MrSGT
For the kinetic analyses, the production rates of sterol 
glucosides were plotted vs. the respective substrate con-
centrations using the SigmaPlot enzyme kinetic module 
(Systat Software Inc., ver. 12.0, San Jose, CA, USA). All 
Fig. 1 Chemical structures of sterols used as acceptors for in vitro MrSGT enzyme reactions
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kinetic data are represented as mean ±SD (n = 3) rela-
tive to the Michaelis–Menten equation. MrSGT reac-
tion kinetics were studied in  vitro, with the reaction 
conditions set at pH 7.5 and 30 °C, and holding the con-
centrations of the three different sterols (β-sitosterol, 
campesterol and cholesterol) constant while varying the 
concentration of UDP-Glc or vice versa. Kinetic param-
eters such as apparent Km, kcat, and kcat/Km values are 
shown in Table 1. Km values for UDP-Glc were all rigid 
within the range of 0.28–0.33  mM, irrespective of the 
type of sterol substrate. On the other hand, the enzyme 
displayed the lowest Km value (0.09 mM) for β-sitosterol 
as the glycosyl acceptor compared to those for campes-
terol and cholesterol (0.28 and 0.45  mM respectively), 
demonstrating that MrSGT prefers β-sitosterol as an 
acceptor to other sterols. Based on the kinetic data 
obtained (Table 1) and the structural features of the three 
sterols (Fig. 1), we were able to speculate on the relation-
ship between the substrate structure and the enzyme’s 
catalytic activity. β-sitosterol and campesterol have the 
characteristic C-24 side-chains as ethyl or methyl deriva-
tives, respectively, whereas cholesterol does not.
Biosynthesis of new PSG derivatives using MrSGT
Additional in  vitro MrSGT reactions with other PSs 
including fucosterol and gramisterol (Fig.  1) were per-
formed to investigate whether the enzyme can catalyze 
the glucosylation of these two PSs. Fucosterol was chosen 
as a candidate acceptor in the MrSGT reaction for exam-
ining the effect of an altered side-chain (namely, an extra 
double bond between C-24 and C-28) on the kinetic 
properties of MrSGT, whereas gramisterol was chosen 
for studying the effect of further structural differences 
including a methyl group at C-4 and C-24, 28 methylene 
group on MrSGT’s catalytic properties. The bioconver-
sion of the above two PSs to their corresponding PSGs 
was detected using HPLC–MS/MS analyses as in the case 
of the previously described sterols (Fig. 2) and the kinetic 
parameters of MrSGT with respect to fucosterol and 
gramisterol were also determined (Table 1). The Km val-
ues for fucosterol and gramisterol as glycosyl acceptors 
averaged at 0.13 and 0.51 mM, respectively, thus demon-
strating recombinant MrSGT’s preference for fucosterol 
as the acceptor over gramisterol. The catalytic efficiency 
of the enzyme was also significantly different with the 
two PSs; kcat/Km values were 56.4 and 15.4 min−1 mM−1 
for fucosterol and gramisterol, respectively (Table 1).
Structural elucidation of fucosterol and gramisterol 
analogs
After multiple scale-up reactions (>5 batches with fucos-
terol) followed by MPLC chromatographic isolation, 
fucosteryl 3-O-glucoside could be obtained as a white 
powder (4.2 mg); HR-ESI–MS ([M + H]+ m/z 575.4233, 
calcd. 575.4267) and 1H- and 13C-NMR (see Table  2). 
HR-ESI–MS of gramisteryl 3-O-glucoside (pale pow-
der, 2.7 mg) gave an m/z of 575.4242 consistent with the 
derived formula of C35H58O6 (575.4267). Its chemical 
structure was further elucidated by NMR spectroscopic 
analyses (see Table 2).
Discussion
The optimal temperature of MrSGT is lower than that 
of the previously characterized bacterial SGTs (Lebrun 
et  al. 2006; Thuan et  al. 2013); and also lower than the 
37 °C optimum of the SGTs present in the human patho-
gen H. pylori and marine actinomycete, S. tropica. When 
the reaction was carried out using β-sitosterol as the 
acceptor and a wide variety of nucleotide sugars (adeno-
sine diphosphate Glc, cytidine diphosphate [CDP]-Glc, 
CDP-galactose [Gal], guanosine diphosphate [GDP]-Glc, 
GDP-Gal, thymidine diphosphate [TDP]-Glc, UDP-Gal, 
UDP-Glc and UDP-glucuronic acid), the glycosylation 
occurred only in the reaction using UDP-Glc as the gly-
cosyl donor. SGT from S. tropica (Thuan et al. 2013) was 
able to utilize TDP-Glc as well as UDP-Glc as glyco-
syl donors for the biosynthesis of β-sitosteryl glucoside. 
Thus, MrSGT differs from the S. tropica-derived SGT in 
its strict substrate specificity with respect to the glycosyl 
moiety donor.
The thorough kinetic analyses revealed that the transfer 
of glucose moiety onto a mammalian sterol or cholesterol 
Table 1 Kinetic parameters for  recombinant MrSGT with  UDP-Glc as  the glycosyl donor and  five different sterols 
as acceptors
Acceptor Donor kcat (min
−1) Km (D) (mM) Km (A) (mM) kcat/Km (A) (min
−1 mM−1)
β-sitosterol UDP-Glc 7.31 ± 1.03 0.28 ± 0.03 0.09 ± 0.01 81.2
Campesterol UDP-Glc 7.66 ± 0.99 0.31 ± 0.04 0.28 ± 0.03 27.4
Cholesterol UDP-Glc 7.90 ± 1.11 0.33 ± 0.06 0.45 ± 0.05 17.5
Fucosterol UDP-Glc 7.33 ± 1.64 0.27 ± 0.04 0.13 ± 0.02 56.4
Gramisterol UDP-Glc 7.83 ± 1.02 0.32 ± 0.05 0.51 ± 0.06 15.4
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can be catalyzed by MrSGT, but at a catalytic efficiency 
(17.5 min−1 mM−1) of only 20 % of that for β-sitosterol 
(81.2  min−1  mM−1). It is, thus, obvious that while 
MrSGT can utilize the two PSs as well as cholesterol as 
substrates, β-sitosterol is its preferred substrate. These 
results are consistent with our previous findings (Hoang 
et  al. 2016) of the highest bioconversion rates obtained 
from the MrSGT reactions with β-sitosterol, but differ 
from the findings on other bacterial SGTs (Smith 1971; 
Lebrun et  al. 2006; Thuan et  al. 2013) which have been 
previously characterized. The two SGTs found in the 
infectious pathogens, H. pylori and Mycoplasma galli-
narum, show absolute substrate specificity to cholesterol, 
and are not known to catalyze the biosynthesis of PSG. 
SGT derived from a marine actinomycete, S. tropica, was 
found to strictly function on β-sitosterol.
As indicated by the significant difference in MrSGT’s 
kinetics with different sterol substrates, the decoration 
of alkene (or ethylidene) group at the C-24 branch or 
the degree of hydrophobicity within this region is likely 
to affect both catalytic efficacy and substrate preference 
of MrSGT. The three-dimensional structure of MrSGT 
could provide valuable insights into the protein–ligand 
(or catalytic site-ligand) interactions.
From the kinetic data (Table  1), the high Km and the 
low kcat/Km values for gramisterol (as 4-methylsterol) 
indicated that the structural alteration near the glycosyla-
tion site (C-3 hydroxyl position) in the sterol backbone 
had an adverse effect on MrSGT’s catalytic activity. It is 
evident from these studies that MrSGT can utilize, albeit 
with different catalytic efficiency, diverse sterols as sub-
strates for the biosynthesis of PSGs, exhibiting its prom-
iscuity towards glycosyl acceptors.
Fucosterol is one of the PSs commonly isolated from 
edible brown algae, and its chemical structure was elu-
cidated in 1966 (Nes et  al. 1966). It exhibits a number 
of beneficial medicinal properties such as antioxidant, 
anti-diabetic, anti-cancerous, anti-inflammatory and 
anti-osteoporotic bioactivities (Abdul et al. 2016). There 
is only one publication about the glycosylated analog of 
fucosterol, which reports the presence of fucosteryl glu-
coside in the neutralized solvent extracts from the tropi-
cal lemongrass herb Cymbopogon citrus (Olaniyi et  al. 
1975). However, the structural details of this analog were 
not elucidated. There are no reports on the enzymatic 
glycosylation of fucosterol. Gramisterol is known as a 
4-methyl PS present mainly in grain germs and kernel 
and vegetable oils (Jeong et  al. 1975). Two recent pub-
lications have reported that gramisterol isolated from 
the rice bran extract displayed not only anti-cancerous 
activity against the mouse leukemia cell line, but also 
anti-tumor and immune enhancing activities against 
acute myelogenous leukemia (Suttiarporn et  al. 2015; 
Somintara et al. 2016). To date, however, there have been 
also no reports on the nature of its glucoside and the 
in vivo or in vitro enzymatic biosynthesis of gramisteryl 
glucoside.
From the listed chemical shifts of NMR spectra 
acquired from both glucosides (Table  2), the anomeric 
proton signal (δH 4.43 or 4.44) present in both gluco-
sides demonstrated the axial (β) resonance, same as that 
found in β-sitosterol-3-O-β-d-glucoside, campesterol-
3-O-β-d-glucoside and cholesterol-3-O-β-d-glucoside 
(Hoang et al. 2016). Moreover, the coupling constant (J) 
within the range of 7.2–7.4 Hz detected at the anomeric 
proton of both glucosides, represented the 180° dihedral 
Fig. 2 HPLC-MS/MS traces of in vitro MrSGT reactions with a fucosterol, b gramisterol, and the MS/MS spectra of c fucosteryl-3-O-glucoside shown 
as product in chromatogram a, d gramisteryl-3-O-glucoside in chromatogram (b)
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angle between the two coupled protons, assigning appar-
ent β-anomer. Therefore, the chemical structures of the 
fucosterol and gramisterol analogues were elucidated as 
fucosterol-3-O-β-d-glucoside and gramisterol-3-O-β-
d-glucoside, respectively. However, these kinds of glu-
cosides with β-conformation are usually the products 
of plant-origin SGT reactions (Chaturvedi et  al. 2011; 
Saema et  al. 2016; Tiwari et  al. 2014). The bacterial 
SGT from H. pylori is known to produce glucoside in 
α-conformation (namely, cholesterol-3-O-α-glucoside) 
(Lebrun et al. 2006). There is no detailed stereo-chemical 
information on the enzymatic products of other bacte-
rial SGTs from S. tropica and M. gallinarum (Smith 1971; 
Thuan et  al. 2013). Hence, this is the first report on a 
stereospecific bacterial SGT which can attach a glucose 
moiety in β-conformation at the C-3 hydroxyl group of 
sterols.
Using the kinetic analyses of UDP-Glc-dependent 
MrSGT, we were able to confirm the promiscuity of 
recombinant MrSGT, in contrast to the previously dis-
covered bacterial SGTs. Exploiting this substrate flexibil-
ity, two new sterol glucosides, whose chemical structures 
have not been described before, were stereo-specifically 
biosynthesized, and their chemical structures were eluci-
dated as fucosterol-3-O-β-d-glucoside and gramisterol-
3-O-β-d-glucoside, respectively. Glycosylation of PSs 
with known bioactivities can augment the structural 
diversity of natural products and make it possible to 
expand the therapeutic applications of PSs by enhancing 
the known bioactivities or endowing them with new bio-
activities. Further studies on the comparison of the bio-
activities of non-glycosylated PSs with those of their PSG 
derivatives should be the direction of future research in 
this area.
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